PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-93.01%
Negative net income growth while CNQ stands at 15.30%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-5.25%
Both reduce yoy D&A, with CNQ at -20.06%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-73.27%
Negative yoy deferred tax while CNQ stands at 21.63%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-522.22%
Both cut yoy SBC, with CNQ at -18.03%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-190.97%
Negative yoy working capital usage while CNQ is 451.11%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-190.97%
Negative yoy usage while CNQ is 451.11%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-72.92%
Both negative yoy, with CNQ at -960.00%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-62.50%
Both yoy CFO lines are negative, with CNQ at -0.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-43.31%
Both yoy lines negative, with CNQ at -1.05%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-243.86%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
43.31%
Purchases growth of 43.31% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
105.31%
Liquidation growth of 105.31% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-68.17%
Both yoy lines negative, with CNQ at -129.30%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-273.43%
Both yoy lines negative, with CNQ at -12.15%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-8211.11%
We cut debt repayment yoy while CNQ is 93.38%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.